Which countries run stem-cell trials for Peripheral Neuropathy?

Country distribution

A study with sites in several countries is counted once per country, taken from the location block of each registry record.

What the map means for Peripheral Neuropathy

Registered work sits in neurology and endocrinology departments; commercially, neuropathy is sold widely alongside supplements and devices. Because symptoms fluctuate with glucose, sleep and activity, this is fertile ground for uncontrolled improvement claims.

Where recruitment is actually open

What travelling for a trial actually involves

Before treating a foreign site as an option, confirm the follow-up burden in writing. Trials measure outcomes on a schedule; missing those visits makes the data unusable and leaves you outside the safety net the protocol provides.

Multi-country studies, named

Registered studies with sites in more than one country — the clearest evidence of collaboration rather than a single-centre series.

• NCT02795052 — Neurologic Stem Cell Treatment Study (United Arab Emirates, United States)

Why trial geography is not a shortlist

Trial locations follow regulation, funding and sponsor headquarters, not clinical quality. Countries with clear conditional pathways for advanced therapies and large public research budgets register more studies. A country appearing here also says nothing about whether commercial clinics there operate under the same oversight as the registered trials.

Before treating geography as a shortlist, read the legality overview by country and what "best country" actually means here.

When these studies started

Registrations by start year since 2020: 2020 (2), 2021 (1), 2022 (4), 2023 (3), 2024 (2), 2025 (3), 2026 (3). Activity for this condition spans 2005 to 2026, which shows whether interest is growing, flat or past its peak.

Frequently asked

Which countries run stem-cell trials for Peripheral Neuropathy?

Sites are registered in 16 countries; the largest is United States (~50% of country mentions, 2026-08-29).

Does a country with many trials mean better treatment there?

Volume tracks funding and law, not outcomes. The relevant question is what oversight covers the specific clinic and product you are considering.

Are trial sites and commercial clinics the same thing?

Mostly no. Some clinics imply an association with local research institutions; the registry record names the actual sponsor and site, which settles it.

Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.